by Reuters | Jun 9, 2023 | Asia, Business, Health, Top News, US
By Leroy Leo and Julie Steenhuysen (Reuters) -A panel of expert advisers on Friday unanimously agreed that a late-stage trial of Eisai and Biogen’s Alzheimer’s drug Leqembi verified the benefit of the treatment for those at an early stage of the disease,...
by Reuters | Jun 6, 2023 | Business, Health, Top News, US
By Michael Erman NEW YORK (Reuters) -Merck & Co sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), which it argues violates the Fifth and First Amendments to the U.S....
by Reuters | Jun 4, 2023 | Business, Economy, Europe, Health, UK
By Natalie Grover LONDON (Reuters) – AstraZeneca’s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data...
by Reuters | Jun 1, 2023 | Business, Health, Top News, US
By Julie Steenhuysen (Reuters) -The U.S. Medicare health plan said on Thursday it would limit reimbursement for Eisai Co Ltd and Biogen Inc’s Alzheimer’s drug Leqembi to patients whose doctors participate in a health agency database should the drug win...
by Reuters | May 19, 2023 | Business, Health, Science, Top News, US
By Pratik Jain (Reuters) -The U.S. Food and Drug Administration on Friday approved Krystal Biotech Inc’s first-of-its kind topical gene therapy for patients with a genetic skin disorder, sending its shares up 7% in afternoon trading. Patients with the rare...
by Reuters | May 13, 2023 | Asia, Business, Canada, Economy, Europe, Health, UK, US
TOKYO (Reuters) -The Group of Seven (G7) rich nations is set to agree on establishing a new programme to distribute vaccines to developing countries at next week’s summit of leaders, Japan’s Yomiuri newspaper said on Saturday. In addition to the G7, G20...
